Franklin Resources’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
82,579
+3,535
| +4% | +$195K | ﹤0.01% | 1391 |
|
|
2025
Q1 | $3.82M | Sell |
79,044
-9,826
| -11% | -$475K | ﹤0.01% | 1435 |
|
|
2024
Q4 | $3.43M | Buy |
88,870
+7,279
| +9% | +$281K | ﹤0.01% | 1514 |
|
|
2024
Q3 | $3.78M | Buy |
81,591
+45,674
| +127% | +$2.12M | ﹤0.01% | 1473 |
|
|
2024
Q2 | $1.24M | Buy |
35,917
+4,073
| +13% | +$141K | ﹤0.01% | 1847 |
|
|
2024
Q1 | $921K | Buy |
+31,844
| New | +$921K | ﹤0.01% | 1980 |
|
|
2023
Q4 | – | Sell |
-11,853
| Closed | -$198K | – | 2691 |
|
|
2023
Q3 | $198K | Sell |
11,853
-29,231
| -71% | -$488K | ﹤0.01% | 2316 |
|
|
2023
Q2 | $1.13M | Buy |
41,084
+8,551
| +26% | +$236K | ﹤0.01% | 1589 |
|
|
2023
Q1 | $2.29M | Buy |
32,533
+17,785
| +121% | +$1.25M | ﹤0.01% | 1322 |
|
|
2022
Q4 | $161K | Buy |
+14,748
| New | +$161K | ﹤0.01% | 2044 |
|